Thom Busby is Partner with Mirus Capital Advisors, a premier middle market investment bank. He has more than a decade of dedicated life science and healthcare investment banking experience and a twenty-year history of successfully raising capital. As an investment banker, he has advised dozens of senior management teams on corporate transactions spanning M&A, divestments, majority/minority recapitalizations, private equity/debt, platform/tuck-in acquisitions, venture capital, strategic build-to-buy investments, partnerships, and bankruptcies.
Thom is sought after by clients for his strategic and creative approach to transacting, deep industry knowledge across medical device, biopharma, diagnostics, instrumentation, and digital health/HCIT, and extensive experience in life science service verticals, including CROs, CDMOs, consultancies, laboratories, and other pharma and medtech partners. A noted expert in his field, Thom is a regular panelist, moderator, writer, and podcast guest discussing middle-market life science transaction activity and trends. Thom is an Executive in Residence at Yale Ventures, a Board member with HealthTech Build, and an Advisory Board Member of the UMASS Chan Bridge Fund. Thom lives on the South Shore with his wife and two children.
Experience
Mirus Capital Advisors, Partner
Outcome Capital, Director
Education
Suffolk University – MBA
Suffolk University – BA
Licenses
Series 63 & 79
FINRA’s BrokerCheck
